Biester T et al. Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study. Diabetes Obes Metab. 2021; 23:599-608. doi : 10.1111/dom.14258 La majorité des patients diabétiques de type 1 (DT1) n’atteignant pas leurs objectifs glycémiques, l’amélioration des traitements […]
Zacay G, et al. Glycemic control and risk of cellulitis. Diabetes Care 2021; 44: 367–372. doi : 10.2337/dc19-1393 Les patients diabétiques présentent une augmentation du risque d’infection. Certaines infections sont pathognomoniques ou alors plus fréquentes au cours du diabète, comme la pyélonéphrite emphysémateuse, la gangrène de Fournier, l’otite externe maligne et la mucormycose. Des […]
Jensen J, et al. Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2021;9:106-116. doi : 10.1016/S2213-8587(20)30382-X Les inhibiteurs du SGLT2 sont en train de sortir du champ […]
Wittert G et al., Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol 2021; 9:32-45. doi : 10.1016/S2213-8587(20)30367-3 Une concentration de testostérone sérique basse est fréquemment retrouvée chez les hommes obèses ou en surpoids et […]
Delicano RA, et al. The shared risk of diabetes between dog and cat owners and their pets: register based cohort study. BMJ 2020; 371: m4337. doi : 10.1136/bmj.m4337 Le diabète de type 2 (DT2) est un enjeu majeur de santé publique du fait du nombre de patients atteints et de l’augmentation de sa prévalence […]
Echouffo-Tcheugui JB, et al. Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes. Diabetes Care 2021; 44: 248–254. doi : 10.2337/dc20-0552 Les hypoglycémies sont plus fréquentes chez les sujets âgés diabétiques, avec un doublement du risque pour chaque décade additionnelle à partir de l’âge de 60 ans […]
Höskuldsdóttir G et al. Potential benefits and harms of gastric bypass surgery in obese individuals with type 1 diabetes: a nationwide, matched, observational cohort study. Diabetes Care 2020; 43:3079–3085. doi : 10.2337/dc20-0388 Si le rôle de la chirurgie bariatrique dans le traitement du diabète de type 2 (DT2) tout comme son impact sur ses […]
Amadou C, Denis P, Cosker K, Fagot-Campagna A. Less amputations for diabetic foot ulcer from 2008 to 2014, hospital management improved but substantial progress is still possible: A French nationwide study. PLoS One. 2020; 15:e0242524. doi : 10.1371/journal.pone.0242524 Les nombreux progrès dans la prise en charge du diabète ont permis (au moins aux Etats-Unis) […]
Rosenstock J, et al. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. N Engl J Med. 2020; 383:2107-16. doi : 10.1056/NEJMoa2022474 L’ensemble des sociétés savantes s’accorde à dire que la prise en charge thérapeutique du diabète de type 2 (DT2) nécessite une escalade thérapeutique dès lors que les objectifs glycémiques ne sont […]
Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study. Diabetologia 2020 ; 63: 2689–2698. doi : 10.1007/s00125-020-05278-2 Le diabète est la première cause d’amputation non traumatique des membres inférieurs (AMI). En plus de son impact fonctionnel et psycho-social, […]
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
